Viewing Study NCT02633059


Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2026-02-11 @ 5:56 AM
Study NCT ID: NCT02633059
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2015-12-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Sponsor: Mayo Clinic
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-12-30
Start Date Type: ACTUAL
Primary Completion Date: 2021-01-31
Primary Completion Date Type: ACTUAL
Completion Date: 2022-11-01
Completion Date Type: ACTUAL
First Submit Date: 2015-12-15
First Submit QC Date: None
Study First Post Date: 2015-12-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2022-07-22
Results First Submit QC Date: None
Results First Post Date: 2022-12-02
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-27
Last Update Post Date: 2024-09-19
Last Update Post Date Type: ACTUAL